Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 09, 2022

BUY
$0.41 - $0.63 $16,400 - $25,200
40,000 New
40,000 $22,000
Q4 2021

Feb 09, 2022

SELL
$0.57 - $1.29 $18,639 - $42,183
-32,700 Closed
0 $0
Q3 2020

Nov 05, 2020

BUY
$1.53 - $3.13 $15,300 - $31,300
10,000 Added 44.05%
32,700 $98,000
Q4 2019

Feb 04, 2020

BUY
$0.62 - $1.06 $14,074 - $24,062
22,700 New
22,700 $19,000

About TREVENA INC


  • Ticker TRVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 173,680,992
  • Market Cap $273M
  • Description
  • Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...
More about TRVN
Track This Portfolio

Track Tobias Financial Advisors, Inc. Portfolio

Follow Tobias Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tobias Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tobias Financial Advisors, Inc. with notifications on news.